Chu, Shuilian
Feng, Lin
Zuo, Yingting
Jing, Hang
Zhang, Di
Tong, Zhaohui
Shi, Ju
Ma, Haomiao
Zhang, Zhijin
Liang, Lirong
Funding for this research was provided by:
Reform and Development Program of Beijing Institute of Respiratory Medicine (ysrh2022014)
Beijing Key Specialists in Major Epidemic Prevention and Control
Financial Budgeting Project of Beijing Institute of Respiratory Medicine (ysbz2022002)
Article History
Received: 20 February 2023
Accepted: 15 March 2023
First Online: 25 March 2023
Declarations
:
: This study protocol has been approved by the Institutional Review Board (IRB) of Beijing Chao-Yang Hospital, Capital Medical University in Beijing, China on December 30, 2020. IRB# 2020-Ke-545.The most recent continuing review was completed on December 15, 2022 (Protocol Version 1.5). The ethics committee granted a waiver of written documentation of informed consent. Electronic informed consent will be obtained from all participants (no e-signature). If there are many significant protocol modifications in the future, we will communicate the modifications to investigators, REC/IRBs, trial participants, trial registries and journals. All methods will be performed in accordance with the Declaration of Helsinki.
: Not applicable because we will not collect or videos of participants in this study. Additionally, no details on individuals are reported within the manuscript.
: The authors declare that they have no competing interests.